Hospital del Mar Barcelona

Barcelona 8003

0 studies enrolling now · 2 studies all time

What they study most

Autoimmune Diseases, Bladder Cancer, Bladder Neoplasm, Blood Coagulation Disorder, Blood Platelet Disorder, Carcinoma, Transitional Cell, Hematologic Diseases, Hemorrhage, Hemorrhagic Disorders, ITP - Immune Thrombocytopenia, Immune System Diseases, Immune Thrombocytopenia

Studies at this site

• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) — Withdrawn before enrolling
• Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder — Completed